No abstract

associated with higher calcium levels (p=0.02 by Cochran-Armitage test).Moreover, the hematoma volume was significantly associated with corrected serum calcium levels (b 0.378, standard error [SE] 0.101, P<0.001) and antiplatelet drug use (b 0.240, SE 0.089, P=0.005). Compared with the control group, the corrected serum calcium levels (OR 1.54, 95% CI 1.07-2.22, P=0.02) were significantly associated with the onset of cerebral hemorrhage, pre-dialysis hypertension (OR 1.40/10 mmHg increase, 95% CI 1.23-1.29, P<0.001), and intact-parathyroid hormone levels (OR 1.03/10 pg/mL increase, 95% CI 1.01-1.05, P=0.02). No significant association was observed between serum calcium levels and any of the aforementioned factors.

associated with higher calcium levels (p=0.02 by Cochran-Armitage test).Moreover, the hematoma volume was significantly associated with corrected serum calcium levels (b 0.378, standard error [SE] 0.101, P<0.001) and antiplatelet drug use (b 0.240, SE 0.089, P=0.005). Compared with the control group, the corrected serum calcium levels (OR 1.54, 95% CI 1.07-2.22, P=0.02) were significantly associated with the onset of cerebral hemorrhage, pre-dialysis hypertension (OR 1.40/10 mmHg increase, 95% CI 1.23-1.29, P<0.001), and intact-parathyroid hormone levels (OR 1.03/10 pg/mL increase, 95% CI 1.01-1.05, P=0.02). No significant association was observed between serum calcium levels and any of the aforementioned factors.